Maternal serum human placental growth hormone (hPGH) at 11 to 13 weeks of gestation in preeclampsia

Hypertension in Pregnancy

Volumn 30, Issue 1, 2011, Pages 74-82

  Sifakis, Stavros ^a   Akolekar, Ranjit ^b   Mantas, Nikitas ^b   Kappou, Dimitra ^a   Nicolaides, Kypros H ^b,c  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Placental growth hormone; Preeclampsia; Pregnancy associated plasma protein A; Uterine artery Doppler

Indexed keywords

GROWTH HORMONE; HUMAN PLACENTAL GROWTH HORMONE; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; PULSE WAVE; UTERINE ARTERY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 79952971981     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2010.486461     Document Type: Article

References (42)

1. Igout A, Scippo ML, Frankenne F, Hennen G. Cloning and nucleotide sequence of placental HG-V and c-DNA. Arch Int Physiol Biochem 1988; 96:63-67.
2. Jara CS, Salud AT, Bryant-Greenwood GD, Pirens G, Hennen G, Frankenne F. Immunocytochemical localization of the human growth hormone variant in the human placenta. J Clin Endocrinol Metab 1989; 69:1069-1072. (Pubitemid 19261841)
3. Liebhaber SA, Urbanek M, Ray J, Tuan RS, Cooke NE. Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest 1989; 83:1985-1991. (Pubitemid 19148870)
4. Scippo ML, Frankenne F, Hooghe-Peters EL, Igout A, Velkeniers B, Hennen G. Syncytiotrophoblastic localization of the human growth hormone variant mRNA in placenta. Mol Cell Endocrinol 1993; 92:R7-R13. (Pubitemid 23124973)
5. Eriksson L, Frankenne F, Eden S, Hennen G, Von Schoultz B. Growth hormone 24-h serum profiles during pregnancy-lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989; 96:949-953. (Pubitemid 19209987)
6. Lacroix MC, Guibourdenche J, Frendo JL, Muller F, Evain-Brion D. Human placental growth hormone-a review. Placenta 2002; 23:S87-S94. (Pubitemid 39658618)
7. Fuglsang J, Ovesen P. Aspects of placental growth hormone physiology. Growth Horm IGF Res 2006; 16:67-85.
8. Caufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993; 265:E572-E577.
9. McIntyre HD, Serek R, Crane DI, Veveris-Lowe T, Parry A, Johnson S, et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: Correlations with fetal growth. J Clin Endocrinol Metab 2000; 85:1143-1150. (Pubitemid 32269363)
10. Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J, et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: Association between placental GH fetal growth. J Clin Endocrinol Metab 2004; 89:384-391 (Pubitemid 38183908)
11. Frankenne F, Alsat E, Scippo ML, Igout A, Hennen G, Evain-Brion D. Evidence for the expression of growth hormone receptors in human placenta. Biochem Biophys Res Commun 1992; 182:481-486.
12. Lacroix MC, Guiboudenche J, Fournier T, Laurendeau I, Igout A, Goffin V, et al. Stimulation of human trophoblast invasion by placental growth hormone. Endocrinology 2005; 146:2434-2444 (Pubitemid 40577531)
13. Schiessl B, Strasburger CJ, Bidlingmaier M, Gutt B, Kirk SE, Oberhoffer R, et al. Role of placental growth hormone in the alteration of maternal arterial resistance in pregnancy. J Reprod Med 2007; 52:313-316 (Pubitemid 46668877)
14. Mittal P, Espinoza J, Hassan S, Kusanovic JP, Edwin SS, Nien JK, et al. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Matern Fetal Neonatal Med 2007; 20:651-659. (Pubitemid 47262701)
15. Moghadam S, Engel W, Bougoussa M, Hennen G, Igout A, Sancken U. Maternal serum placental growth hormone and insulin-like growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: Implications for prenatal diagnosis of trisomy 21. Fetal Diagn Ther 1998; 13:291-297. (Pubitemid 28522146)
16. Papadopoulou E, Sifakis S, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E, et al. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Horm IGF Res 2006; 16:290-296. (Pubitemid 44793713)
17. De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123:164-174.
18. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049-1059. (Pubitemid 16004866)
19. Pijnenborg R. The placental bed. Hypertens Pregnancy 1996; 15:7-23. (Pubitemid 26161595)
20. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18:583-586. (Pubitemid 34063054)
21. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30:742-749. (Pubitemid 47612696)
22. Poon LCY, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Hypertensive disorders in pregnancy: Screening by uterine artery Doppler at 11-13 weeks. Ultrasound Obstet Gynecol 2009; 34:142-148.
23. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009; 33:23-33.
24. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, et al. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 1994; 71:560-566. (Pubitemid 24338164)
25. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96:3149-153. (Pubitemid 29148859)
26. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999; 14:90-96. (Pubitemid 30040667)
27. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352:343-346. (Pubitemid 28352196)
28. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31:618-624.
29. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV.
30. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein- A: Impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31:493-502.
31. Guidice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997; 176:751-757.
32. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000; 85:1828-1833. (Pubitemid 32269284)
33. Altinkaynak K, Aksoy H, Bakan E, Kumtepe Y. Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia. Clin Biochem 2003; 36:221-223. (Pubitemid 36515129)
34. Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004; 84:214-219. (Pubitemid 38314761)
35. Kocyigit Y, Bayhan G, Atamer A, Atamer Y. Serum levels of leptin, insulin-like growth factor- I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 2004; 18:341-348. (Pubitemid 38916355)
36. Ning Y, Williams MA, Vadachkoria S, Muy-Rivera M, Frederick IO, Luthy DA. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem 2004; 37:968-973. (Pubitemid 39388657)
37. Sowers M, Scholl T, Grewal J, Chen X, Jannausch M. IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrinol Metab 2001; 86:5898-5903. (Pubitemid 33152642)
38. Hübinette A, Lichtenstein P, Brismar K, Vatten L, Jacobsen G, Ekbom A, et al. Serum insulin- like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 2003; 82:1004-1009. (Pubitemid 37311036)
39. Vatten LJ, Nilsen TI, Juul A, Jeansson S, Jenum PA, Eskild A. Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol 2008; 158:101-105. (Pubitemid 351211046)
40. Mirlesse V, Frankenne F, Alsat E, Poncelet M, Hennen G, Evain-Brion D. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res 1993; 34:439-442. (Pubitemid 23297171)
41. Chowen JA, Evain-Brion D, Pozo J, Alsat E, Garcia- Segura LM, Argente J. Decreased expression of placental growth hormone in intrauterine growth retardation. Pediatr Res 1996; 39:736-739. (Pubitemid 26128161)
42. Barrio E, Calvo MT, Miramar MD, Lorente F, Rodriguez A, Labarta JI, et al. Study of apoptosis and related proteins, CRH and hpGH in placentas of newborns small for gestational age (SGA). Pediatr Endocrinol Rev 2009; 6:337-342.